Multiplex Nanoparticles with Polymer Brushes for Selective Cell Targeting

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current drug delivery systems face challenges in achieving high selectivity for target sites, leading to undesirable side effects and reduced efficacy due to non-specific interactions, especially in crowded biological environments like cancer tissues, where both healthy and diseased cells express similar receptors.

Innovation Solution

Development of multiplex nanoparticles or microparticles with multiple different ligand types on their surface, combined with a polymer brush, to enhance selective binding to specific cell receptors, reducing off-target interactions and receptor mutation evasion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a single ligand type is used on the nanoparticle surface, then the binding affinity to a specific receptor is high, but the selectivity is reduced and off-target binding occurs because both healthy and diseased cells express similar receptors

Engineering Contradiction:
Improvebinding affinityVSAvoidoff-target binding
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The single ligand type is segmented into multiple different ligand types (e.g., Ligand 1, Ligand 2, Ligand 3) that can bind to different receptor types (Receptor A, Receptor B, Receptor C). This segmentation allows the nanoparticle to distinguish between healthy and diseased cells by requiring a specific combination of receptors to be present for effective binding, thereby reducing off-target binding while maintaining binding affinity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The nanoparticle surface is designed as a composite structure with multiple ligand types attached to the polymer brush. This composite approach creates a multiplex targeting system where the combination of different ligands working together provides enhanced selectivity. The composite material strategy allows simultaneous engagement with multiple receptor types, creating a more specific binding profile that distinguishes target cells from non-target cells.

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If multiple different ligand types are used on the nanoparticle surface, then the selectivity for target sites is improved, but the device complexity increases due to optimizing ligand numbers and types

Engineering Contradiction:
ImproveselectivityVSAvoidligand configuration complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The polymer brush structure serves as a universal platform that can accommodate multiple different ligand types. The brush architecture provides a common attachment mechanism and spatial organization that simplifies the integration of diverse ligands. This multi-functional design allows the same polymer brush framework to support various ligand configurations for different targeting scenarios, reducing the overall complexity compared to designing separate systems for each ligand type.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system allows for adjustable parameters such as the number of each ligand type, their spatial distribution, and their relative concentrations on the nanoparticle surface. By optimizing these parameters rather than fixing a rigid complex structure, the system achieves high selectivity while maintaining manageable complexity. The parameter-based approach enables flexible tuning of targeting properties without requiring complete redesign of the nanoparticle architecture.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If a high dosing amount is used to overcome non-specific interactions, then the binding to target cells is sufficient, but the undesirable side effects increase

Engineering Contradiction:
Improvebinding efficacyVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The nanoparticle surface exhibits local quality variations with different ligand types distributed across the surface, each targeting specific receptor types. This localized targeting capability allows the system to achieve effective binding at lower concentrations by concentrating binding interactions at the correct target sites while minimizing non-specific interactions elsewhere. The local quality approach creates high binding efficacy with reduced dosing requirements, thereby reducing side effects.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach improves the selective delivery of therapeutic agents to target sites, reducing side effects and maintaining effectiveness over prolonged treatment courses by optimizing ligand numbers and types on the nanoparticle surface, ensuring precise targeting and stability.

Implementation Method 1

a polymer brush on its external surface

Methodology Applied
Scientific EffectSteric stabilization:

Implementation Method 2

multiple different ligand types on its external surface which are capable of binding to different respective receptor types on said cell surface

Methodology Applied
Scientific EffectMolecular recognition:

Data Source

PatentUS12257344B2Polymersomes functionalised with multiple ligands
Publication Date: 2025.03.25 UCL BUSINESS LTD
  • US12257344B2 patent drawing
  • US12257344B2 patent drawing
  • US12257344B2 patent drawing

AI summary

The present invention is directed to a nanoparticle or microparticle for binding to the surface of a cell, wherein the nanoparticle or microparticle comprises (i) multiple different ligand types on its external surface which are capable of binding to different respective receptor types on said cell surface, and (ii) a polymer brush on its external surface. The present invention is further directed to pharmaceutical compositions comprising a plurality of nanoparticles or microparticles of the invention, medical uses of such nanoparticles or microparticles, and a vaccine comprising such nanoparticles or microparticles.